F. Kornalík, The influence of snake venom enzymes on blood coagulation., in Pharmacol Ther, vol. 29, n. 3, 1985, pp. 353-405, PMID 3915360.
HC. Kwaan, Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism., in Thromb Diath Haemorrh Suppl, vol. 56, 1973, pp. 239-51, PMID 4617331.
AS. Gallus, J. Hirsh, Treatment of venous thromboembolic disease., in Semin Thromb Hemost, vol. 2, n. 4, Apr 1976, pp. 291-331, PMID 798277.
RL. Soutar, JS. Ginsberg, Anticoagulant therapy with ancrod., in Crit Rev Oncol Hematol, vol. 15, n. 1, Ago 1993, pp. 23-33, PMID 8240705.
JG. Wright, G. Geroulakos, Ancrod: clinical indications and methods of use., in Semin Vasc Surg, vol. 9, n. 4, Dic 1996, pp. 315-28, PMID 8958608.
WR. Bell, Defibrinogenating enzymes., in Drugs, 54 Suppl 3, 1997, pp. 18-30; discussion 30-1, PMID 9360849.
HA. Reid, Therapeutic defibrination by ancrod (Arvin)., in Folia Haematol Int Mag Klin Morphol Blutforsch, vol. 95, n. 2, 1971, pp. 209-15, PMID 4106010.
CP. Olinger, TG. Brott; WG. Barsan; JR. Hedges; P. Glas-Greenwalt; VE. Pollak; J. Spilker; R. Eberle, Use of ancrod in acute or progressing ischemic cerebral infarction., in Ann Emerg Med, vol. 17, n. 11, Nov 1988, pp. 1208-9, PMID 3056131.
JJ. Muñoz-Torrero, FJ. Mora; E. Díez-Tejedor, [Specific treatment of the acute cerebral infarct. Present and future]., in Rev Neurol, vol. 31, n. 10, pp. 959-82, PMID 11244692.
DG. Sherman, RP. Atkinson; T. Chippendale; KA. Levin; K. Ng; N. Futrell; CY. Hsu; DE. Levy, Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial., in JAMA, vol. 283, n. 18, maggio 2000, pp. 2395-403, PMID 10815082.
